Paul Hoelscher

(Mr. Paul Hoelscher)

Currently holds positions in Horizon Therapeutics PLC and Horizon Pharmaceutical LLC

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Horizon Therapeutics PLC Oct. 1, 2014 -
Director Horizon Pharmaceutical LLC Oct. 25, 2016 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-22 2022-04-20
PS Planned sale
21,542 -95.4%
115.17
USD 2,480,992 		21,542 -95.4% 115.17 USD 2,480,992
2022-04-22 2022-04-20
PS Planned sale
28,458 -55.7%
114.36
USD 3,254,457 		28,458 -55.7% 114.36 USD 3,254,457
2022-04-08 2022-04-06
PS Planned sale
91,710 -57.9%
110.01
USD 10,089,026 		91,710 -57.9% 110.01 USD 10,089,026
2022-04-08 2022-04-06
PS Planned sale
215,335 -99.5%
110.01
USD 23,688,788 		215,335 -99.5% 110.01 USD 23,688,788
2022-03-25 2022-03-25
PS Planned sale
663 -0.4%
110.00
USD 72,930 		663 -0.4% 110.00 USD 72,930
2022-03-25 2022-03-24
PS Planned sale
1,481 -0.9%
110.00
USD 162,910 		1,481 -0.9% 110.00 USD 162,910
2022-03-25 2022-03-23
PS Planned sale
11,699 -6.8%
110.01
USD 1,287,018 		11,699 -6.8% 110.01 USD 1,287,018
2022-03-25 2022-03-23
PS Planned sale
26,090 -96.1%
110.00
USD 2,870,002 		26,090 -96.1% 110.00 USD 2,870,002
2020-08-25 2020-08-24
PS Planned sale
1,823 -1.7%
76.23
USD 138,967 		1,823 -1.7% 76.23 USD 138,967
2020-08-25 2020-08-24
PS Planned sale
27,753 -20.9%
75.73
USD 2,101,735 		27,753 -20.9% 75.73 USD 2,101,735
2020-05-07 2020-05-05
PS Planned sale
104,994 -44.2%
38.00
USD 3,989,772 		104,994 -44.2% 38.00 USD 3,989,772
2019-10-17 2019-10-15
PS Planned sale
10,000 -6.7%
28.00
USD 280,000 		10,000 -6.7% 28.00 USD 280,000
2019-10-17 2019-10-15
PS Planned sale
10,000 -6.3%
28.01
USD 280,100 		10,000 -6.3% 28.01 USD 280,100
2019-09-04 2019-08-30
PS Planned sale
1,359 -0.8%
28.00
USD 38,052 		1,359 -0.8% 28.00 USD 38,052
// ... existing code ... // ... rest of the file ...